Why BGPT?
logo

Assess an author's data and outputs

See the raw experimental evidence behind an author's publications and reproducibility signals.







Press Enter ↵ to solve



    Fuel Your Discoveries




     Quick Explanation



    Peng Cao — scientific strength (skeptical, evidence-based)
    Based on the limited author metadata you provided (h-index=6; 22 papers; ~160 citations) and the listed paper titles (dominated by mechanical/structural engineering topics rather than biological mechanisms), I would rate Peng Cao’s current *biological science* evidence strength as modest-to-low. I cannot reliably match “Peng Cao” to the biology-rich DOIs in the provided research records, so any biology-specific credit would be speculative and I therefore withhold it.
    If you share Peng Cao’s ORCID or a verified publication list with DOIs, I can re-score with high confidence and produce paper-by-paper mechanistic rigor checks.



     Long Explanation



    Author Review: Peng Cao
    Epistemic status: Your input contains (i) author-level metrics (h-index/citations/paper count) and (ii) a large set of biological/biomedical papers with DOIs and detailed “research data”. However, the provided “research data” does not explicitly verify that these DOIs correspond to Peng Cao. Without an unambiguous mapping (e.g., ORCID, full DOI-bearing author list), I cannot correctly attribute biological work to this author.
    Therefore: This review weights your provided author metrics + the listed Peng Cao paper titles most heavily, and treats the biology-rich research records as unattributed context.
    1) Citation-metric snapshot (from your metadata)
    2) Field orientation inferred from listed paper titles
    Skeptical interpretation: The titles you provided appear overwhelmingly centered on mechanical/structural engineering (finite element modeling, fracture mechanics, asphalt/pavement/tunnels, composite structures). That suggests either (a) Peng Cao’s training/output is primarily in engineering, or (b) the dataset you provided is incomplete/biased toward one subdomain.
    Blind spot: Titles alone do not guarantee biological relevance or experimental rigor; but they do strongly limit what biological credit can be responsibly assigned.
    3) Evidence-quality rubric (how I scored “scientific strength”)
    • Attribution integrity (highest priority): I cannot safely map Peng Cao to the biomedical DOIs in the “research data” block you supplied, so I do not grant biology-specific rigor/novelty credit from those records.
    • Track record proxies: h-index, total citations, and paper count were used only as broad signals of community uptake.
    • Domain mismatch risk: If the author’s work is engineering-heavy, biology-science “god-tier” claims would be unjustified.
    • Reproducibility & methods opacity: Without full papers, I cannot directly audit sample sizes, controls, blinding/randomization, statistical corrections, code availability, or effect sizes.
    4) What can be said about scientific strength vs uncertainty
    Known from your data:
    • Peng Cao: h-index = 6, total citations = 160, paper count = 22 (as provided).
    • Listed publications emphasize mechanics/pavement/tunnel/composite/fracture simulation and materials testing (inferred from titles).
    Unknown / cannot responsibly infer:
    • Whether these papers include robust experimental designs (controls, replication, blinding), code/data releases, or benchmark comparisons.
    • Whether “Peng Cao” is the same person as any of the DOIs in your biology-focused research records.
    5) Counterpoints & how to disprove my scoring
    • If you provide DOI-bearing lists for Peng Cao showing substantial contributions to biological sciences with high-quality methods (well-controlled mechanistic work, strong statistics, reproducible code), then the biological-science rigor/quality scores should rise.
    • If Peng Cao’s engineering papers include highly cited methodological advances (not just incremental case studies), then the overall scientific strength score should also rise.
    • If the author metrics are name-collation artifacts (common name “Peng Cao”), the citation-based proxy could be misleading. ORCID would resolve this.
    6) Score summary (requested fields are filled in the JSON output)
    Note: I’m explicitly treating this as a critical, evidence-limited assessment because attribution and paper-level method details are missing.
    Biology DOIs you supplied (NOT attributed to Peng Cao): Example works include a medical-literature mining foundation model (LEADS) and spatial transcriptomics enhancement (STPAINTER), but I did not assign authorship credit to Peng Cao because the mapping is not explicit in your input. For transparency, here are the biomedical research-record anchors you provided:
    These citations are included only to satisfy the constraint that I must cite biomedical claims I explicitly reference; they are not used to score Peng Cao.


    Feedback:   

    Updated: April 03, 2026

    BGPT Author Review



    Scientific Quality

    40%

    Moderate-low scientific strength score driven by limited evidence access: (1) your provided author metrics (h-index 6, ~160 citations, 22 papers) suggest some community uptake but not strong top-tier impact; (2) the listed publication titles appear largely engineering/mechanics rather than biological mechanistic science, limiting biological scoring; (3) crucial paper-level rigor details (sample sizes, controls, statistics, reproducibility) are not included; (4) the supplied biomedical DOI research records cannot be confidently mapped to Peng Cao, so I withheld biology credit to avoid attribution error.



    Communication Quality

    60%

    Cannot directly evaluate communication quality from the provided input. The available content is metadata-heavy (metrics/titles) rather than writing samples, so the score reflects information scarcity rather than judged clarity.



    Author Novelty

    30%

    No reliable novelty assessment is possible without reading the papers. Title-level patterns suggest incremental applied engineering work, and I cannot responsibly credit novelty in biology without DOI-mapped authorship evidence.



    Scientific Rigor

    30%

    Paper-level methodological rigor is not auditable from the provided titles/metrics. Without access to full methods, statistical treatment, blinding/randomization (when relevant), and data/code availability, rigor must be scored conservatively.

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    A graveyard hypothesis is that Peng Cao’s biological-science rigor can be inferred from the biomedical DOIs in your provided research block; this is currently the wrong explanation because authorship linkage is not explicitly verified in your input.


    Another weak hypothesis is that high citation counts necessarily imply high experimental rigor; citation impact can reflect broader utility, collaboration networks, or even field size changes, so citations alone can mislead.

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion








    Get Ahead With Science Insights

    Custom summaries of the latest cutting edge Science research. Every Friday. No Ads.


    My BGPT